No Photo Available

Last Update

2016-07-18T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Yi Shi?

Dr. Yi Shi PhD

Managing Director

Lilly Asia Ventures

Direct Phone: +86 ** **** ****       

Email: y***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Lilly Asia Ventures

Hong Kong,

China

Company Description

Lilly Asia Ventures, founded in 2008, is dedicated to venture capital investments in the life sciences and healthcare sectors in Asia, particularly in China. Its investors include Eli Lilly & Co., a Fortune 500 company and one of the most globalized and i ... more

Find other employees at this company (9)

Background Information

Employment History

Management Consultant

Ernst & Young LLP

Affiliations

Board Member
Innovent Biologics , Inc.

Board Member
Chipscreen Biosciences Co. , Ltd.

Board Member
HD Biosciences Co. Ltd

Board Member
Beta Pharma

Board Member
SinqiPharma

Board Member
BrightGene Biomedical

Education

Bachelor of Science

Biology

University of Science and Technology of China

Master of Business Administration degree

Duke University

Ph.D.

Biochemistry

Duke University

Web References (46 Total References)


Lilly Asia Ventures Invests $10 Million in CanSino_Tianjin CanSino Biotechnology Inc. (CanSino)

www.cansinotech.com [cached]

Darren Carroll, Lilly¡¯s Global Vice President, and Dr. Yi Shi, Lilly Asia Ventures¡¯ Managing Director,


ACEA Biosciences Announces the Successful Completion of 30 Million USD in Venture FundingLilly Asia Ventureswww.lillyasiaventures.com

www.lillyasiaventures.com [cached]

"We are excited to form our partnership with ACEA," said Dr. Yi Shi, Managing Director of Lilly Asia Ventures.


ACEA Biosciences Announces the Successful Completion of 30 Million USD in Venture FundingLilly Asia Ventureswww.lillyasiaventures.com

www.lillyasiaventures.com [cached]

"We are excited to form our partnership with ACEA," said Dr. Yi Shi, Managing Director of Lilly Asia Ventures.


BioCapital China Summit 2009 - Speaker Bios

www.chinabiollc.com [cached]

Yi Shi, PhD - Managing Director, Lilly Asian Ventures

Dr. Yi Shi joined Lilly Asian Ventures in 2007 as a Managing Director based in Shanghai, China. Prior to the current assignment, he worked in various roles with increasing responsibility over six years at Eli Lilly and Company. His experience includes leading the development of a comprehensive investment strategy for China as well as negotiating multiple biotechnology and pre-clinical deals world-wide. Dr. Shi was also instrumental in the founding of InnoCentive, Inc., a Lilly Ventures portfolio company, where he managed scientific operations as well as its expansion into China. Before joining Lilly, Dr. Shi was the Chief Sales and Marketing Officer of NetBig.com, an internet start-up, where he successfully grew the company to become the number one education and technology portal in China. He began his career as a management consultant with Ernst & Young in the Life Science Practice Group and specialized in sales and marketing strategy. Dr. Shi received a Ph.D. in Biochemistry and a Master of Business Administration degree, both from Duke University. He also earned a Bachelor of Science in Biology from the University of Science and Technology of China.


bioBAY Investor Forum 2008 - Suzhou - Speaker Bios

www.chinabiollc.com [cached]

Yi Shi, PhD - Managing Director, Lilly Asian Ventures

Dr. Yi Shi joined Lilly Asian Ventures in 2007 as a Managing Director based in Shanghai, China. Prior to the current assignment, he worked in various roles with increasing responsibility over six years at Eli Lilly and Company. His experience includes leading the development of a comprehensive investment strategy for China as well as negotiating multiple biotechnology and pre-clinical deals world-wide. Dr. Shi was also instrumental in the founding of InnoCentive, Inc., a Lilly Ventures portfolio company, where he managed scientific operations as well as its expansion into China.
Before joining Lilly, Dr. Shi was the Chief Sales and Marketing Officer of NetBig.com, an internet start-up, where he successfully grew the company to become the number one education and technology portal in China. He began his career as a management consultant with Ernst & Young in the Life Science Practice Group and specialized in sales and marketing strategy. Dr. Shi received a Ph.D. in Biochemistry and a Master of Business Administration degree, both from Duke University. He also earned a Bachelor of Science in Biology from the University of Science and Technology of China.

Similar Profiles

Other People with this Name

Other people with the name Shi

Danny Shi
CB Richard Ellis Inc

Tina Shi

Iris Shi
Wal-Mart Stores , Inc.

Sherry Shi
Incisive Media Limited

Steven Shi
Atlas Advisors LLC

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory